7Baggers
 strs ohio invests $315,000 in atea pharmaceuticals, inc. $avir  MarketBeat Wed, 24 Sep 2025 07:32:20 GMT
 atea pharmaceuticals, inc. (nasdaq:avir) short interest update  MarketBeat Mon, 22 Sep 2025 22:45:10 GMT
 atea pharmaceuticals, inc. (nasdaq:avir) short interest update  MarketBeat Fri, 19 Sep 2025 09:20:36 GMT
 Insiders Enjoy US$723k Return After Buying Atea Pharmaceuticals Stock  simplywall.st Fri, 19 Sep 2025 07:00:00 GMT
 published on: 2025-09-12 16:19:18  Newser Fri, 12 Sep 2025 21:19:18 GMT
 nuveen llc buys shares of 291,091 atea pharmaceuticals, inc. $avir  Defense World Thu, 04 Sep 2025 00:28:29 GMT

Atea Pharmaceuticals, Inc
(NASDAQ:AVIR) 

AVIR stock logo

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, a novel antiviral agent that is in Phase II clinical trial for th...

CEO: Jean-Pierre Sommadossi  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends